"
Vascular markers CD31, CD34, actin, VEGFB, and VEGFR2, are prognostic markers for malignant development in benign endometrial polyps"
written by Bodil Hvingel, Marit Lieng, Borghild Roald, Anne Ørbo,
published by
Open Journal of Obstetrics and Gynecology,
Vol.2 No.1, 2012
has been cited by the following article(s):
|
[1]
|
Expression of CD34 and α-SMA Markers in Oral Squamous Cell Carcinoma Differentiation. A Histological and Histo-Chemical Study
International Journal of Environmental Research and Public Health,
2020
DOI:10.3390/ijerph18010192
|
|
|
|
|
[2]
|
Implication of VEGFR2 in endometriosis: A structural biological and genetic approach
World Academy of Sciences Journal,
2019
DOI:10.3892/wasj.2019.29
|
|
|
|
|
[3]
|
Induction of apoptosis, anti-proliferation, tumor-angiogenic suppression and down-regulation of Dalton’s Ascitic Lymphoma (DAL) induced tumorigenesis by poly-l-lysine: A mechanistic study
Biomedicine & Pharmacotherapy,
2018
DOI:10.1016/j.biopha.2018.03.076
|
|
|
|
|
[4]
|
Induction of apoptosis, anti-proliferation, tumor-angiogenic suppression and down-regulation of Dalton’s Ascitic Lymphoma (DAL) induced tumorigenesis by poly-l-lysine: A mechanistic study
Biomedicine & Pharmacotherapy,
2018
DOI:10.1016/j.biopha.2018.03.076
|
|
|
|